SMDPY OTC
Sumitomo Pharma Co., Ltd.
1W: -1.1%
1M: +11.1%
3M: +11.7%
YTD: -9.8%
1Y: -6.1%
$10.32
-0.12 (-1.20%)
Weekly Expected Move ±7.5%
$9
$10
$10
$11
$12
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$76.0B
+360.8% ▲
5Y CAGR: -10.9%
Capital Expenditures
$4.9B
+62.5% ▲
5Y CAGR: -14.7%
Free Cash Flow
$71.2B
+1950.5% ▲
5Y CAGR: -10.6%
Dividends Paid
$2M
+29.3% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$19.8B
+433.9% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $40.6B | -$96.7B | -$314.9B | $23.6B | $113.3B |
| Depreciation & Amort. | $38.3B | $41.3B | $37.8B | $25.6B | $22.0B |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$33.7B | $34.9B | -$95.8B | -$18.8B | $2.0B |
| Other Non-Cash Items | -$14.0B | $32.5B | $131.1B | -$13.9B | -$61.3B |
| Operating Cash Flow | $31.2B | $11.9B | -$241.9B | $16.5B | $76.0B |
| — Investing Activities — | |||||
| Capital Expenditures | -$13.5B | -$12.7B | -$15.7B | -$8.5B | -$7.8B |
| Acquisitions (Net) | -$3.7B | $30.2B | $8.6B | $1.5B | $32.8B |
| Investment Purchases | -$25.9B | -$6.2B | -$4.8B | -$1.6B | -$5.8B |
| Investment Sales | $19.5B | $10.1B | $34.5B | $108.5B | $4.5B |
| Other Investing | $5.3B | $31.2B | $10.4B | -$52M | $214M |
| Investing Cash Flow | -$18.3B | $52.4B | $33.0B | $99.8B | $23.9B |
| — Financing Activities — | |||||
| Net Debt Issuance | -$4.9B | $65.5B | $84.0B | -$112.5B | -$93.7B |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$11.1B | -$11.1B | -$2.8B | -$3M | -$2M |
| Other Financing | -$5.4B | -$201.2B | -$3.4B | $3.7B | -$3.0B |
| Financing Cash Flow | -$21.4B | -$146.8B | $77.9B | -$108.8B | -$96.8B |
| Net Change in Cash | $9.3B | -$59.5B | -$114.4B | -$5.9B | $19.8B |
| Cash End of Period | $203.0B | $143.5B | $29.0B | $23.1B | $44.5B |
| Free Cash Flow | $17.7B | -$805M | -$257.6B | $3.5B | $71.2B |